Low Dose of Diltiazem for Rate Control of Atrial Fibrillation

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00834925

Enrollment

380

Registered

2009-02-03

Start date

2009-08-31

Completion date

2011-08-31

Last updated

2011-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

atrial fibrillation with rapid ventricular response

Brief summary

This study is to show the efficacy and safety of low dose diltiazem for the treatment of atrial fibrillation with rapid ventricular response in emergency room. We will compare the standard dose of diltiazem(0.25mg/kg) with low dose diltiazem(0.1mg/kg)in atrial fibrillation with rapid ventricular response in ED.

Interventions

DRUGlow dose diltiazem

Low dose diltiazem: 0.15mg/kg over 2 minutes Standard dose diltiazem: 0.25mg/kg over 2 minutes

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* atrial fibrillation with rapid ventricular response in emergency room

Exclusion criteria

* age\<18 * systolic blood pressure\<90mmHg * no consent

Design outcomes

Primary

Measure	Time frame
Success rate of rate control	in 30 minutes

Countries

South Korea

Contacts

Primary ContactKyuseok Kim

dremkks@snubh.org+82-31-787-3049

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026